Suchergebnisse - "Antonarakis, Emmanuel S"

PubPharm (526)

101

Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer

enthalten in: Cancer immunology immunotherapy | 2021

von Kaur, H. | Vidotto, T. | Mendes, A. | +4

102

Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer

enthalten in: Cancer immunology immunotherapy | 2021

von Kaur, H. | Vidotto, T. | Mendes, A. | +4

103

Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2021

von Markowski, M. | Velho, P. | Eisenberger, M. | +6

104

Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer : Recommendations for Advancing Precision Medicine

enthalten in: European urology open science | 2021

von Jasu, J. | Tolonen, T. | Antonarakis, E. | +26

105

Mismatch repair-deficient prostate cancer with parenchymal brain metastases treated with immune checkpoint blockade

enthalten in: Cold Spring Harbor molecular case studies | 2021

von Sena, L. | Salles, D. | Engle, E. | +4

106

Olaparib and rucaparib for the treatment of DNA repair-deficient metastatic castration-resistant prostate cancer

enthalten in: Expert opinion on pharmacotherapy | 2021

von Maughan, B. | Antonarakis, E.

107

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Brown, L. | Halabi, S. | Schonhoft, J. | +21

108

TGM4 : an immunogenic prostate-restricted antigen

enthalten in: Journal for immunotherapy of cancer | 2021

von Lopez-Bujanda, Z. | Obradovic, A. | Nirschl, T. | +15

109

Genomic profiles and clinical outcomes in primary versus secondary metastatic hormone-sensitive prostate cancer

enthalten in: The Prostate | 2021

von Nizialek, E. | Lim, S. | Wang, H. | +3

110

Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2021

von Lotan, T. | Kaur, H. | Salles, D. | +10